Logo: Four dots and StockDot set in typeface Coolvetica
An interactive map about institutional investors and their engagement in the stock market
Equity Distribution for INTELLIA THERAPEUTICS Inc
Ticker NTLA
FIGI BBG007KC7PB0
CUSIP 45826J105
Sector Healthcare
Equity Type Common Stock
No. Companies Holding this Equity 273 / 4.0%
Percentage held by institutional investors 100.0%

About

Intellia Therapeutics, Inc. is an American clinical-stage biotechnology company focused on developing novel, potentially curative therapeutics leveraging CRISPR-based technologies. The company's in vivo programs use intravenously administered CRISPR as the therapy, in which the company's proprietary delivery technology enables highly precise editing of disease-causing genes directly within specific target tissues. Wikipedia